Lv01
0 积分 2025-05-13 加入
Selective JAK1 inhibitors and the therapeutic applications thereof: a patent review (2016-2023)
7小时前
待确认
A Comprehensive Overview of Globally Approved JAK Inhibitors
8小时前
已完结
The role of the JAK/STAT3 signaling pathway in acquired corneal diseases
9小时前
已完结
Treatment of Vernal Keratoconjunctivitis Using Upadacitinib
9小时前
已完结
Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model
9小时前
已完结
皖公网安备34019202002308
